| Trial Identifier: | D1690R00004 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT02695082 |
| Start Date: | January 2017 |
| Primary Completion Date: | September 2020 |
| Study Completion Date: | November 2020 |
| Condition: | Kidneys & Urinary - Other |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| United Kingdom | London, United Kingdom |
| United States of America, DC | Washington DC, DC, United States of America |
| United States of America, DE | Wilmington, DE, United States of America |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company